Patents-Review.com
ClassID:

94807 ⎘

C07D281/02 - CPC Classification

Classification description:

Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms Seven-membered rings

Sub-classes:
Recent Application in this class:
#1
20250206714
2025-06-26

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES

 #2
20240092802
2024-03-21

MU-OPIOID RECEPTOR AGONISTS AND USES THEREFOR

 #3
20230373940
2023-11-23

CARBOXYLIC DIARYLTHIAZEPINEAMINES AND USES THEREOF

 #4
20230365519
2023-11-16

CARBOXYLIC DIARYLTHIAZEPINEAMINES AND USES THEREOF

 #5
20230082516
2023-03-16

15-PGDH INHIBITOR

 #6
20220259165
2022-08-18

S-OXIDES OF 2,3-DIARYL-2,3-DIHYDRO-4H-1,3-THIAZIN-4-ONES AND 2,3-DIARYL-1,3-THIAZEPAN-4-ONES AND METHODS FOR MAKING

 #7
20220227723
2022-07-21

2,3-diaryl-1,3-thiazepan-4-ones compounds and methods for making

 #8
20220106279
2022-04-07

CLASS OF MU-OPIOID RECEPTOR AGONISTS

 #9
20200276208
2020-09-03

Tianeptine oxalate salts and polymorphs

 #10
20200079745
2020-03-12

Carboxylic diarythiazepineamines as mixed mu- and delta-opioid receptor agonists

 #11
20190084949
2019-03-21

NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS

 #12
20190077798
2019-03-14

2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides

 #13
20190047970
2019-02-14

Carboxylic diarylthiazepineamines as mu-opioid receptor agonists

 #14
20190002454
2019-01-03

NRF2 Regulators

 #15
20180362543
2018-12-20

HIV REPLICATION INHIBITOR

 #16
20180338984
2018-11-29

Tianeptine oxalate salts and polymorphs

 #17
20180051016
2018-02-22

2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides

 #18
20170217913
2017-08-03

Class of mu-opioid receptor agonists

 #19
20160318917
2016-11-03

Nrf2 regulators

 #20
20160237049
2016-08-18

Crystal modifications of elobixibat

 #21
20160229822
2016-08-11

Crystal modifications of elobixibat

 #22
20160039777
2016-02-11

Crystal modifications of elobixibat

 #23
20150361093
2015-12-17

HIV REPLICATION INHIBITOR

 #24
20150210680
2015-07-30

AMINODIHYDROTHIAZINE DERIVATIVES

 #25
20140243317
2014-08-28

Dibenzothiazepine derivatives and their use in the treatment of CNS disorders

 #26
20140121368
2014-05-01

Process for preparing benzothiazepines from gamma-aminoalkylbenzenes

 #27
20140058097
2014-02-27

Pharmaceutical composition for treating alzheimer's disease

 #28
20140031330
2014-01-30

Aryl sultam derivatives as RORc modulators

 #29
20130303755
2013-11-14

Aminodihydrothiazine derivatives

 #30
20120022249
2012-01-26

Aminodihydrothiazine derivatives

 #31
20120016116
2012-01-19

Aminodihydrothiazine derivatives

 #32
20110112068
2011-05-12

Human immunodeficiency virus protease inhibitors

 #33
20100160290
2010-06-24

Pharmaceutical composition for treating Alzheimer's disease

 #34
20100112051
2010-05-06

Tianeptine sulfate salt forms and methods of making and using the same

 #35
20090227788
2009-09-10

Process for preparing benzothiazepines from gamma-aminoalkylbenzenes

 #36
20090082560
2009-03-26

Aminodihydrothiazine derivatives

 #37
20080221081
2008-09-11

Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S dioxide and methods of making and using the same

 #38
20080132450
2008-06-05

Pharmaceutical composition for suppression of apoptosis and method for delivering the same

 #39
20050234038
2005-10-20

Protease inhibitors

 #40
20050143576
2005-06-30

Process for production of high-purity enamines

 #41
20050009755
2005-01-13

Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient